Fundraising: Crucial for Translational Researchers Medical device development is expensive, time-consuming, and uncertain—and virtually none of it happens without outside capital. For translational researchers making the transition from lab to startup, fundraising is often unfamiliar territory, requiring a different kind of persuasion than a grant application or a journal submission. Investors aren't evaluating the elegance of your science; they're assessing whether your device solves a real clinical problem, whether the market is large enough to justify the risk, and whether your team has what it takes to navigate the long road from concept to commercialized product. Understanding the funding landscape — the sources available, the stages involved, and the expectations attached to each—is not peripheral to your development journey. It's central to it.